Picture of Wakamoto Pharmaceutical logo

4512 — Wakamoto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Table: Wakamoto Pharm - 6-MTH parent results

Oct 30 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2019        Sep 30, 2018      Mar 31, 2020  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             5.38                5.23              11.30     
                 (+3.0 pct)          (-3.6 pct)        (+5.2 pct)   
  Operating     loss 900 mln         loss 44 mln      loss 900 mln  
  Recurring     loss 886 mln         loss 29 mln      loss 900 mln  
  Net             loss 1.62          loss 31 mln        loss 1.65   
  EPS          loss 46.76 yen       loss 0.91 yen    loss 47.54 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T

Recent news on Wakamoto Pharmaceutical

See all news